Institution
National Chemical Laboratory
Facility•Pune, Maharashtra, India•
About: National Chemical Laboratory is a facility organization based out in Pune, Maharashtra, India. It is known for research contribution in the topics: Catalysis & Enantioselective synthesis. The organization has 8891 authors who have published 14837 publications receiving 387600 citations.
Topics: Catalysis, Enantioselective synthesis, Nanoparticle, Zeolite, Adsorption
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The enhanced biocompatibility of polymer modified, P-GQDs, is attributed to reduced reactive oxygen species generation, as measured by an intracellular ROS assay.
Abstract: Despite the promising photophysical properties of fluorescent graphene quantum dots (GQDs), their cellular toxicity needs to be addressed before their full potential could be completely realized in biomedicine. A simple method for mitigating the toxicity of GQDs by embedding them in PEG matrix is reported here. The enhanced biocompatibility of polymer modified, P-GQDs, is attributed to reduced reactive oxygen species generation, as measured by an intracellular ROS assay. We also demonstrate the enhanced loading and efficient intracellular delivery of therapeutics by P-GQDs.
89 citations
••
TL;DR: The fungal based fabrication provides an economical, green chemistry approach for production of highly fluorescent CdTe quantum dots and shows antibacterial activity against Gram positive and Gram negative bacteria.
89 citations
••
TL;DR: In this article, the surface Ni/alkaline earth(s) ratio for all the catalysts is decreased; the decrease is, however, very large for the NiO-SrO and all the BaO containing catalysts.
89 citations
••
TL;DR: Treatment with methyl-β-cyclodextrin (MCD), a cholesterol depleting agent, increases the efficacy of tamoxifen in melanoma cells and may provide a unique therapeutic window for improvement in melan cancer treatment.
Abstract: Despite modern advances in treatment, skin cancer is still one of the most common causes of death in the western countries. Chemotherapy plays an important role in melanoma management. Tamoxifen has been used either alone or in- combination with other chemotherapeutic agents to treat melanoma. However, response rate of tamoxifen as a single agent has been comparatively low. In the present study, we investigated whether treatment with methyl-β-cyclodextrin (MCD), a cholesterol depleting agent, increases the efficacy of tamoxifen in melanoma cells. This was a two-part study that incorporated in vitro effects of tamoxifen and MCD combination by analyzing cell survival, apoptosis and cell cycle analysis and in vivo antitumor efficacy on tumor isografts in C57BL/6J mice. MCD potentiated tamoxifen induced anticancer effects by causing cell cycle arrest and induction of apoptosis. Sensitization to tamoxifen was associated with down regulation of antiapoptotic protein Bcl-2, up-regulation of proapoptotic protein Bax, reduced caveolin-1 (Cav-1) and decreased pAkt/pERK levels. Co-administration of tamoxifen and MCD caused significant reduction in tumor volume and tumor weight in mice due to enhancement of drug uptake in the tumor. Supplementation with cholesterol abrogated combined effect of tamoxifen and MCD. Our results emphasize a potential synergistic effect of tamoxifen with MCD, and therefore, may provide a unique therapeutic window for improvement in melanoma treatment.
89 citations
••
TL;DR: In this article, the nitration of benzaldehyde can be carried out in a safe manner in continuous mode using a microreactor system using a T-micromixer.
89 citations
Authors
Showing all 8913 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ashok Kumar | 151 | 5654 | 164086 |
Rajesh Kumar | 149 | 4439 | 140830 |
Tak W. Mak | 148 | 807 | 94871 |
John T. O'Brien | 121 | 819 | 63242 |
Clive Ballard | 117 | 736 | 61663 |
Yoshinori Tokura | 117 | 858 | 70258 |
John S. Mattick | 116 | 367 | 64315 |
Michael Dean | 107 | 419 | 63335 |
Ian G. McKeith | 107 | 468 | 51954 |
David J. Burn | 100 | 446 | 39120 |
Anil Kumar | 99 | 2124 | 64825 |
Vikas Kumar | 89 | 859 | 39185 |
Detlef W. Bahnemann | 88 | 517 | 48826 |
Gautam R. Desiraju | 88 | 458 | 45301 |
Praveen Kumar | 88 | 1339 | 35718 |